The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments

Peer Review reports

Original Submission
5 Nov 2010	Submitted	Original manuscript
7 Feb 2011	Reviewed	Reviewer Report - Letizia Mazzini
7 Feb 2011	Reviewed	Reviewer Report - Franca Fagioli
18 Feb 2011	Author responded	Author comments - Peter Connick
Resubmission - Version 2
18 Feb 2011	Submitted	Manuscript version 2
Publishing
2 Mar 2011	Editorially accepted
2 Mar 2011	Article published	10.1186/1745-6215-12-62

Back to article page